| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
125,094 |
111,220 |
$17.78M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
120,349 |
106,867 |
$15.71M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
49,438 |
42,771 |
$7.59M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
208,790 |
150,348 |
$6.55M |
| 99215 |
Prolong outpt/office vis |
37,883 |
34,376 |
$5.52M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
34,393 |
31,238 |
$5.29M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
13,144 |
10,910 |
$5.07M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
27,294 |
24,409 |
$4.64M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
33,488 |
27,172 |
$4.54M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
16,528 |
12,279 |
$3.87M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
5,155 |
4,996 |
$3.40M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
4,284 |
4,159 |
$3.26M |
| G0378 |
Hospital observation service, per hour |
25,991 |
12,237 |
$2.89M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
12,327 |
7,786 |
$2.84M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
19,482 |
16,058 |
$2.55M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
26,735 |
25,945 |
$2.11M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13,178 |
12,737 |
$2.08M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14,141 |
13,662 |
$1.97M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
30,262 |
27,339 |
$1.95M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
29,324 |
10,235 |
$1.52M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
8,090 |
7,718 |
$1.42M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
4,561 |
4,316 |
$1.38M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,419 |
8,212 |
$1.34M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,634 |
1,592 |
$1.33M |
| 59025 |
Fetal non-stress test |
5,158 |
2,906 |
$1.32M |
| 70450 |
Computed tomography, head or brain; without contrast material |
10,504 |
9,501 |
$1.30M |
| 96415 |
|
2,738 |
2,137 |
$1.19M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
20,825 |
15,863 |
$1.17M |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
1,003 |
981 |
$1.03M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,124 |
2,306 |
$969K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,533 |
7,157 |
$960K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,481 |
1,108 |
$891K |
| 31575 |
|
3,458 |
3,296 |
$812K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
5,100 |
5,017 |
$794K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
6,757 |
5,576 |
$786K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
24,278 |
20,099 |
$703K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
2,442 |
2,357 |
$680K |
| 99205 |
Prolong outpt/office vis |
4,439 |
4,303 |
$679K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
4,708 |
4,026 |
$653K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
141,735 |
112,163 |
$637K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,349 |
1,277 |
$634K |
| 96367 |
|
4,315 |
2,791 |
$622K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
19,599 |
17,344 |
$620K |
| J9271 |
Injection, pembrolizumab, 1 mg |
60 |
48 |
$613K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
757 |
710 |
$592K |
| 31231 |
|
2,299 |
2,206 |
$563K |
| 20610 |
|
3,970 |
3,439 |
$558K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
5,783 |
5,673 |
$554K |
| J0178 |
Injection, aflibercept, 1 mg |
1,220 |
1,096 |
$552K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
4,370 |
3,934 |
$543K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
19,564 |
18,622 |
$502K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
7,267 |
7,125 |
$495K |
| 71046 |
Radiologic examination, chest; 2 views |
28,539 |
26,479 |
$493K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
19,080 |
18,188 |
$489K |
| 76770 |
|
3,025 |
2,897 |
$481K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
7,385 |
6,770 |
$479K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,553 |
4,095 |
$475K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
4,817 |
4,738 |
$472K |
| 17110 |
|
2,070 |
1,988 |
$468K |
| 74183 |
|
1,514 |
1,484 |
$461K |
| 90834 |
Psychotherapy, 45 minutes with patient |
13,577 |
6,222 |
$460K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,119 |
4,104 |
$454K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
3,678 |
3,575 |
$444K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,904 |
3,892 |
$440K |
| 97803 |
|
6,294 |
5,749 |
$432K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
4,500 |
3,781 |
$423K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
4,279 |
4,191 |
$421K |
| 76830 |
Ultrasound, transvaginal |
4,043 |
3,920 |
$409K |
| 71250 |
|
4,873 |
4,736 |
$399K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
37,112 |
36,031 |
$393K |
| 93325 |
|
3,178 |
3,029 |
$393K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
4,262 |
4,198 |
$386K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,399 |
1,301 |
$370K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
9,665 |
8,670 |
$357K |
| 11900 |
|
1,578 |
1,542 |
$355K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,478 |
3,366 |
$344K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
18,816 |
6,702 |
$342K |
| 97010 |
|
5,822 |
1,972 |
$341K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,463 |
3,900 |
$330K |
| 52000 |
|
616 |
593 |
$323K |
| 92567 |
|
9,075 |
8,833 |
$322K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,824 |
3,683 |
$316K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,980 |
2,967 |
$316K |
| 84443 |
Thyroid stimulating hormone (TSH) |
32,127 |
30,447 |
$303K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,358 |
1,323 |
$300K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
15,885 |
14,077 |
$296K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,873 |
1,760 |
$295K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
5,293 |
4,954 |
$292K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
2,731 |
2,644 |
$276K |
| 80053 |
Comprehensive metabolic panel |
56,291 |
45,194 |
$274K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
3,823 |
2,987 |
$263K |
| 92557 |
|
4,703 |
4,503 |
$262K |
| 76536 |
|
2,118 |
2,094 |
$254K |
| 36430 |
|
835 |
552 |
$253K |
| 97162 |
|
3,892 |
3,495 |
$252K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,989 |
1,944 |
$249K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,392 |
17,199 |
$245K |
| 90836 |
|
4,877 |
3,422 |
$240K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
16,680 |
15,968 |
$237K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
48,738 |
46,223 |
$229K |
| 83735 |
|
61,781 |
43,288 |
$223K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,651 |
1,541 |
$222K |
| 80051 |
|
70,374 |
57,611 |
$219K |
| 77080 |
|
4,143 |
3,945 |
$211K |
| 93971 |
|
954 |
880 |
$209K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
11,782 |
11,422 |
$207K |
| 76642 |
|
1,742 |
1,665 |
$204K |
| 97802 |
|
2,653 |
2,567 |
$197K |
| 92015 |
Determination of refractive state |
10,067 |
9,883 |
$193K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
86 |
67 |
$193K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
46,592 |
40,535 |
$186K |
| 86833 |
|
1,538 |
1,405 |
$183K |
| 90832 |
Psychotherapy, 30 minutes with patient |
9,616 |
5,891 |
$178K |
| 85027 |
|
43,022 |
38,093 |
$177K |
| 93975 |
|
1,273 |
1,208 |
$177K |
| 90686 |
|
15,100 |
14,809 |
$176K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
93 |
75 |
$172K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
106 |
105 |
$171K |
| 86480 |
|
4,073 |
3,917 |
$168K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
17,458 |
16,292 |
$165K |
| 86832 |
|
1,662 |
1,522 |
$163K |
| 11102 |
|
368 |
363 |
$161K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,275 |
3,033 |
$154K |
| 84702 |
|
13,801 |
11,907 |
$152K |
| 87536 |
|
3,775 |
3,580 |
$151K |
| 92134 |
|
11,568 |
10,746 |
$149K |
| 90715 |
|
7,409 |
7,200 |
$143K |
| 87660 |
|
9,311 |
8,863 |
$141K |
| 82728 |
|
18,173 |
17,060 |
$141K |
| 80061 |
Lipid panel |
39,121 |
37,437 |
$139K |
| J1453 |
Injection, fosaprepitant, 1 mg |
751 |
502 |
$138K |
| 20611 |
|
357 |
328 |
$138K |
| 87510 |
|
8,852 |
8,433 |
$138K |
| J7050 |
Infusion, normal saline solution, 250 cc |
7,346 |
4,595 |
$137K |
| 87480 |
|
8,855 |
8,435 |
$134K |
| 94010 |
|
1,883 |
1,814 |
$133K |
| 83970 |
|
8,205 |
7,716 |
$131K |
| 72100 |
|
4,811 |
4,665 |
$130K |
| 82565 |
|
80,447 |
66,549 |
$129K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
1,527 |
1,320 |
$129K |
| 0002A |
|
4,058 |
3,939 |
$128K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,589 |
1,520 |
$127K |
| 86780 |
|
12,672 |
12,254 |
$125K |
| 84484 |
|
15,499 |
12,589 |
$123K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
23,851 |
20,406 |
$122K |
| 84520 |
|
77,804 |
64,098 |
$119K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
568 |
559 |
$118K |
| 92083 |
|
6,570 |
6,344 |
$117K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
31,583 |
26,236 |
$117K |
| 88342 |
|
7,362 |
6,877 |
$115K |
| 93017 |
|
1,590 |
1,528 |
$114K |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
113 |
38 |
$114K |
| 86850 |
|
19,806 |
17,233 |
$113K |
| 84466 |
|
15,377 |
14,634 |
$111K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,671 |
1,415 |
$111K |
| 0001A |
|
4,074 |
3,956 |
$109K |
| 86803 |
|
11,791 |
11,370 |
$108K |
| 92587 |
|
1,059 |
1,047 |
$104K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
4,555 |
4,429 |
$104K |
| 72141 |
|
438 |
428 |
$101K |
| 83880 |
|
6,904 |
6,034 |
$100K |
| 97161 |
|
1,380 |
1,242 |
$98K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
75 |
73 |
$97K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,824 |
1,810 |
$97K |
| 85730 |
|
23,737 |
19,596 |
$97K |
| 99385 |
|
913 |
908 |
$96K |
| 76801 |
|
870 |
815 |
$95K |
| 82947 |
|
56,341 |
45,584 |
$95K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
513 |
491 |
$93K |
| 82607 |
|
11,719 |
11,187 |
$92K |
| 84460 |
|
52,528 |
45,497 |
$91K |
| 85610 |
|
35,118 |
27,360 |
$90K |
| 92133 |
|
7,684 |
7,411 |
$90K |
| 94726 |
|
1,589 |
1,518 |
$89K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
15,636 |
12,233 |
$88K |
| 93296 |
|
2,328 |
2,235 |
$86K |
| 83690 |
|
18,332 |
16,542 |
$86K |
| 84100 |
|
52,962 |
36,641 |
$85K |
| 88307 |
|
1,403 |
1,275 |
$85K |
| 92551 |
|
658 |
653 |
$85K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
22,958 |
19,622 |
$84K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,909 |
5,393 |
$84K |
| 76813 |
|
832 |
826 |
$84K |
| 87517 |
|
2,988 |
2,837 |
$81K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
4,359 |
4,240 |
$81K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
229 |
220 |
$80K |
| 82247 |
|
44,626 |
38,119 |
$79K |
| 86140 |
|
23,357 |
20,578 |
$79K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
36 |
28 |
$78K |
| 11100 |
|
275 |
267 |
$77K |
| 84450 |
|
52,403 |
45,392 |
$77K |
| 76827 |
|
1,810 |
1,372 |
$75K |
| 80050 |
General health panel |
6,096 |
5,775 |
$75K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
4,513 |
4,105 |
$74K |
| 87340 |
|
10,403 |
9,728 |
$73K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
1,878 |
1,586 |
$73K |
| 92060 |
|
2,840 |
2,788 |
$72K |
| 72197 |
|
218 |
213 |
$70K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
66 |
64 |
$69K |
| 20550 |
|
321 |
311 |
$68K |
| 73030 |
|
5,827 |
5,246 |
$66K |
| 0004A |
|
2,602 |
2,537 |
$66K |
| 83540 |
|
17,103 |
16,250 |
$66K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13,013 |
11,899 |
$65K |
| 84075 |
|
43,528 |
37,162 |
$64K |
| 76825 |
|
1,201 |
1,155 |
$64K |
| 92579 |
|
2,094 |
2,064 |
$64K |
| 73564 |
|
5,346 |
5,050 |
$63K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
3,124 |
2,869 |
$62K |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
18 |
17 |
$60K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,147 |
1,467 |
$60K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,461 |
875 |
$59K |
| 92020 |
|
1,171 |
1,126 |
$59K |
| 92553 |
|
880 |
860 |
$58K |
| 82570 |
|
19,787 |
17,596 |
$58K |
| 36415 |
Collection of venous blood by venipuncture |
97,061 |
82,779 |
$58K |
| 90791 |
Psychiatric diagnostic evaluation |
606 |
595 |
$57K |
| 94729 |
|
1,855 |
1,785 |
$56K |
| 86706 |
|
7,939 |
7,600 |
$56K |
| 86360 |
|
3,312 |
3,095 |
$56K |
| 86901 |
|
16,945 |
14,730 |
$55K |
| 64615 |
|
136 |
133 |
$55K |
| 83615 |
|
33,748 |
25,165 |
$55K |
| 99173 |
|
1,143 |
1,139 |
$55K |
| 71271 |
|
1,028 |
1,017 |
$54K |
| 73630 |
|
6,168 |
5,372 |
$54K |
| 86900 |
|
20,355 |
17,665 |
$54K |
| 82784 |
|
5,202 |
4,669 |
$53K |
| 90837 |
Psychotherapy, 53 minutes with patient |
460 |
324 |
$53K |
| 88112 |
|
1,451 |
1,310 |
$53K |
| 73130 |
|
4,532 |
4,010 |
$53K |
| 84153 |
|
5,153 |
4,915 |
$52K |
| 82310 |
|
23,144 |
17,373 |
$51K |
| ATP14 |
|
8,466 |
6,755 |
$50K |
| 81025 |
|
7,163 |
6,684 |
$50K |
| 84439 |
|
8,381 |
7,986 |
$49K |
| 91322 |
|
699 |
690 |
$48K |
| 81001 |
|
23,583 |
21,015 |
$48K |
| 73610 |
|
6,288 |
5,240 |
$47K |
| 82043 |
|
17,687 |
15,933 |
$46K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14,152 |
11,615 |
$46K |
| 92555 |
|
1,768 |
1,734 |
$45K |
| 71045 |
Radiologic examination, chest; single view |
7,374 |
6,411 |
$45K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
4,161 |
2,515 |
$45K |
| 72050 |
|
1,047 |
1,025 |
$45K |
| 81002 |
|
24,663 |
21,134 |
$45K |
| 86359 |
|
3,126 |
2,925 |
$44K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,349 |
1,218 |
$43K |
| 84550 |
|
24,432 |
18,099 |
$43K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
825 |
555 |
$43K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
11,150 |
10,971 |
$43K |
| 82746 |
|
5,614 |
5,318 |
$42K |
| 70486 |
|
998 |
949 |
$42K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
48 |
39 |
$40K |
| 85652 |
|
20,844 |
18,852 |
$40K |
| 84480 |
|
4,697 |
4,417 |
$40K |
| 86334 |
|
2,777 |
2,436 |
$39K |
| 31579 |
|
63 |
63 |
$39K |
| 83655 |
|
3,410 |
3,367 |
$39K |
| 70496 |
|
250 |
242 |
$39K |
| 92025 |
|
1,227 |
1,183 |
$39K |
| 82248 |
|
29,269 |
25,136 |
$38K |
| 87070 |
|
6,937 |
6,273 |
$38K |
| 81003 |
|
18,064 |
16,655 |
$37K |
| 73562 |
|
2,771 |
2,343 |
$36K |
| J2704 |
Injection, propofol, 10 mg |
11,784 |
11,055 |
$36K |
| 88341 |
|
2,063 |
1,849 |
$36K |
| 69210 |
|
1,504 |
1,436 |
$35K |
| 87522 |
Neg quan hep c or qual rna |
1,376 |
1,272 |
$35K |
| 82948 |
|
11,697 |
7,796 |
$35K |
| 73110 |
|
3,965 |
3,207 |
$35K |
| ATP07 |
|
5,813 |
4,530 |
$34K |
| 94060 |
|
263 |
251 |
$33K |
| 84403 |
|
1,953 |
1,877 |
$33K |
| 93350 |
|
143 |
143 |
$33K |
| 83516 |
|
2,863 |
2,646 |
$33K |
| 99220 |
|
989 |
559 |
$33K |
| 92550 |
|
446 |
421 |
$32K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
335 |
328 |
$32K |
| 90838 |
|
326 |
185 |
$32K |
| J1756 |
Injection, iron sucrose, 1 mg |
791 |
310 |
$32K |
| 82105 |
|
3,231 |
3,061 |
$32K |
| 73502 |
|
3,710 |
3,451 |
$32K |
| 87799 |
|
2,858 |
2,127 |
$32K |
| 46221 |
|
39 |
39 |
$31K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
431 |
429 |
$31K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
15,375 |
12,112 |
$31K |
| 90677 |
|
1,539 |
1,492 |
$31K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
6,730 |
5,839 |
$31K |
| 94760 |
|
9,901 |
8,292 |
$31K |
| 86704 |
|
3,951 |
3,735 |
$30K |
| 82040 |
|
18,506 |
15,343 |
$29K |
| 87040 |
|
3,004 |
2,479 |
$29K |
| 84156 |
|
14,525 |
12,441 |
$29K |
| 86038 |
|
3,441 |
3,319 |
$28K |
| 88142 |
|
1,667 |
1,636 |
$28K |
| 86235 |
|
765 |
609 |
$28K |
| 84155 |
|
9,442 |
7,287 |
$27K |
| 87186 |
|
5,295 |
4,805 |
$27K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,018 |
4,591 |
$27K |
| 87653 |
|
1,107 |
1,091 |
$27K |
| 86762 |
|
2,324 |
2,246 |
$27K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
29 |
26 |
$26K |
| 86160 |
|
1,689 |
1,413 |
$26K |
| Q3014 |
Telehealth originating site facility fee |
16,912 |
14,655 |
$24K |
| 85007 |
|
9,348 |
7,467 |
$24K |
| 80069 |
|
6,273 |
5,615 |
$23K |
| 91200 |
|
342 |
326 |
$23K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
112 |
103 |
$23K |
| 86923 |
|
620 |
484 |
$23K |
| 73560 |
|
2,048 |
1,843 |
$23K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
753 |
558 |
$22K |
| 96401 |
|
140 |
94 |
$22K |
| 83001 |
|
1,412 |
1,386 |
$22K |
| 80076 |
|
8,061 |
7,171 |
$21K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
77 |
77 |
$21K |
| 77066 |
Tomosynthesis, mammo |
351 |
341 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,708 |
1,627 |
$21K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
650 |
637 |
$20K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
413 |
233 |
$20K |
| 0064A |
|
809 |
778 |
$20K |
| 83605 |
|
2,749 |
2,363 |
$20K |
| 87081 |
|
3,658 |
3,547 |
$20K |
| ATP08 |
|
4,627 |
3,709 |
$20K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
174 |
167 |
$20K |
| 90651 |
|
1,298 |
1,293 |
$20K |
| 84146 |
|
1,173 |
1,139 |
$20K |
| 76937 |
|
1,274 |
1,129 |
$19K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
3,701 |
3,534 |
$19K |
| 72170 |
|
2,959 |
2,717 |
$19K |
| 90480 |
|
704 |
698 |
$19K |
| 84165 |
|
3,687 |
3,270 |
$19K |
| 0012A |
|
692 |
677 |
$19K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,374 |
7,880 |
$19K |
| 86787 |
|
1,848 |
1,749 |
$19K |
| 77065 |
Tomosynthesis, mammo |
283 |
270 |
$19K |
| 73080 |
|
1,759 |
1,531 |
$18K |
| 80197 |
|
5,461 |
3,709 |
$18K |
| ATP15 |
|
4,075 |
2,885 |
$18K |
| 84402 |
|
870 |
850 |
$18K |
| G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk |
13 |
13 |
$18K |
| 82150 |
|
4,269 |
3,699 |
$18K |
| J1644 |
Injection, heparin sodium, per 1000 units |
4,145 |
1,899 |
$18K |
| ATP12 |
|
2,742 |
2,150 |
$18K |
| 51798 |
|
1,241 |
1,136 |
$18K |
| 82550 |
|
10,017 |
8,775 |
$18K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
4,364 |
3,909 |
$17K |
| 87077 |
|
3,749 |
3,192 |
$17K |
| 83883 |
|
2,118 |
1,727 |
$17K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,154 |
5,268 |
$17K |
| ATP17 |
|
3,654 |
2,794 |
$17K |
| 72081 |
|
1,837 |
1,789 |
$17K |
| 90734 |
|
1,692 |
1,681 |
$17K |
| 90670 |
|
3,083 |
3,028 |
$17K |
| 97166 |
|
226 |
210 |
$17K |
| 86580 |
|
922 |
852 |
$17K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
957 |
878 |
$17K |
| 87205 |
|
5,651 |
4,934 |
$17K |
| 97163 |
|
189 |
178 |
$16K |
| 87486 |
|
701 |
661 |
$16K |
| 97750 |
|
433 |
413 |
$16K |
| 20552 |
|
104 |
99 |
$16K |
| G0379 |
Direct admission of patient for hospital observation care |
161 |
125 |
$16K |
| 84703 |
|
2,832 |
2,716 |
$16K |
| 70491 |
|
129 |
127 |
$16K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
892 |
817 |
$15K |
| 88304 |
|
2,782 |
2,698 |
$15K |
| ATP09 |
|
3,111 |
2,102 |
$15K |
| 87147 |
|
2,793 |
2,437 |
$15K |
| 58300 |
|
50 |
50 |
$15K |
| 0124A |
|
662 |
641 |
$15K |
| 87497 |
|
1,303 |
867 |
$15K |
| 85380 |
|
2,076 |
1,878 |
$14K |
| 88313 |
|
1,810 |
1,665 |
$14K |
| J3490 |
Unclassified drugs |
2,791 |
2,178 |
$14K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
58 |
42 |
$14K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
4,775 |
3,718 |
$14K |
| 92523 |
|
78 |
71 |
$14K |
| 83002 |
|
856 |
837 |
$13K |
| 92585 |
|
43 |
42 |
$13K |
| 0011A |
|
678 |
671 |
$13K |
| 62323 |
|
25 |
25 |
$12K |
| 43235 |
|
14 |
13 |
$12K |
| 85046 |
|
3,636 |
3,064 |
$12K |
| 90620 |
|
184 |
183 |
$12K |
| 84425 |
|
814 |
790 |
$12K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
3,444 |
2,959 |
$12K |
| 86039 |
|
1,532 |
1,479 |
$12K |
| 82670 |
|
491 |
478 |
$12K |
| 64642 |
|
77 |
66 |
$12K |
| 73522 |
|
1,480 |
1,432 |
$12K |
| 73140 |
|
1,185 |
1,053 |
$12K |
| 82274 |
|
1,099 |
1,068 |
$12K |
| 93320 |
|
847 |
823 |
$12K |
| 0072A |
|
275 |
272 |
$12K |
| 86003 |
|
101 |
93 |
$11K |
| 86225 |
|
1,074 |
1,016 |
$11K |
| C9257 |
Injection, bevacizumab, 0.25 mg |
426 |
400 |
$11K |
| 82652 |
|
432 |
419 |
$11K |
| 99386 |
|
146 |
144 |
$11K |
| 0071A |
|
267 |
262 |
$11K |
| 0031A |
|
436 |
428 |
$11K |
| 74018 |
|
550 |
507 |
$10K |
| 92552 |
|
136 |
136 |
$10K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,563 |
1,236 |
$10K |
| ATP10 |
|
2,434 |
1,965 |
$10K |
| 86255 |
|
969 |
898 |
$10K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
2,171 |
2,016 |
$9K |
| 0134A |
|
393 |
370 |
$9K |
| 36591 |
|
1,805 |
1,188 |
$9K |
| 73590 |
|
2,088 |
1,809 |
$9K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
75 |
69 |
$9K |
| 85379 |
|
1,406 |
1,344 |
$9K |
| 10060 |
|
43 |
41 |
$9K |
| 95886 |
|
38 |
38 |
$8K |
| ATP13 |
|
1,391 |
1,211 |
$8K |
| 86790 |
|
1,027 |
970 |
$8K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
28 |
15 |
$8K |
| 72040 |
|
416 |
399 |
$8K |
| 83520 |
|
607 |
568 |
$8K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,395 |
2,394 |
$8K |
| 95816 |
|
27 |
27 |
$8K |
| 83021 |
|
443 |
406 |
$8K |
| 87581 |
|
351 |
330 |
$8K |
| 91300 |
|
8,480 |
7,376 |
$8K |
| 87088 |
|
1,656 |
1,513 |
$7K |
| 88185 |
|
34 |
31 |
$7K |
| 77336 |
|
87 |
50 |
$7K |
| 70544 |
|
128 |
123 |
$7K |
| 76818 |
|
142 |
96 |
$7K |
| 93970 |
|
40 |
38 |
$7K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
546 |
543 |
$7K |
| 82435 |
|
491 |
465 |
$7K |
| 87341 |
|
717 |
695 |
$7K |
| 77062 |
|
68 |
67 |
$7K |
| 92582 |
|
343 |
341 |
$7K |
| 97165 |
|
77 |
67 |
$7K |
| 87506 |
|
60 |
60 |
$7K |
| 92250 |
|
1,105 |
1,025 |
$7K |
| 86431 |
|
1,649 |
1,589 |
$7K |
| 82610 |
|
1,190 |
1,108 |
$6K |
| G0008 |
Administration of influenza virus vaccine |
4,711 |
4,451 |
$6K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
342 |
318 |
$6K |
| 11104 |
|
12 |
12 |
$6K |
| 90656 |
|
1,204 |
1,183 |
$6K |
| 83550 |
|
2,762 |
2,620 |
$6K |
| 86618 |
|
435 |
424 |
$6K |
| 74021 |
|
484 |
453 |
$6K |
| 90691 |
|
240 |
237 |
$6K |
| 82378 |
|
582 |
461 |
$6K |
| ATP06 |
|
1,656 |
1,354 |
$6K |
| ATP11 |
|
1,493 |
1,240 |
$6K |
| 51741 |
|
257 |
231 |
$6K |
| 76000 |
|
273 |
262 |
$5K |
| 96405 |
|
101 |
100 |
$5K |
| 86141 |
|
548 |
529 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,694 |
1,388 |
$5K |
| 86304 |
|
481 |
389 |
$5K |
| 70498 |
|
132 |
130 |
$5K |
| 90694 |
|
670 |
649 |
$5K |
| 82951 |
|
478 |
403 |
$5K |
| 84166 |
|
590 |
526 |
$5K |
| 83721 |
|
2,436 |
2,315 |
$5K |
| 96417 |
|
1,009 |
699 |
$5K |
| 93356 |
|
353 |
328 |
$4K |
| 72082 |
|
255 |
227 |
$4K |
| 76512 |
|
28 |
26 |
$4K |
| 36000 |
|
612 |
538 |
$4K |
| 86200 |
|
454 |
443 |
$4K |
| 82747 |
|
346 |
341 |
$4K |
| 92136 |
|
690 |
667 |
$4K |
| 29580 |
|
83 |
13 |
$4K |
| 76519 |
|
39 |
39 |
$4K |
| 86677 |
|
312 |
308 |
$4K |
| 82803 |
|
307 |
242 |
$4K |
| 94618 |
|
38 |
37 |
$4K |
| 73552 |
|
420 |
377 |
$4K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
691 |
618 |
$4K |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
40 |
25 |
$4K |
| ATP03 |
|
5,323 |
4,781 |
$4K |
| 77061 |
|
44 |
44 |
$4K |
| J1815 |
Injection, insulin, per 5 units |
1,006 |
380 |
$4K |
| 83020 |
|
356 |
348 |
$4K |
| ATP04 |
|
2,458 |
2,044 |
$4K |
| ATP16 |
|
972 |
704 |
$4K |
| 95250 |
|
163 |
155 |
$4K |
| 87802 |
|
393 |
386 |
$4K |
| 96376 |
|
3,699 |
2,501 |
$4K |
| 12011 |
|
12 |
12 |
$4K |
| 76942 |
|
91 |
71 |
$4K |
| 87102 |
|
477 |
426 |
$4K |
| 82533 |
|
280 |
253 |
$4K |
| 82950 |
|
806 |
798 |
$4K |
| 84436 |
|
678 |
635 |
$4K |
| 11719 |
|
491 |
481 |
$4K |
| 90662 |
|
860 |
799 |
$3K |
| 91306 |
|
658 |
648 |
$3K |
| 76870 |
|
55 |
52 |
$3K |
| 93304 |
|
13 |
12 |
$3K |
| 86765 |
|
300 |
288 |
$3K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
2,140 |
1,168 |
$3K |
| 77300 |
|
14 |
12 |
$3K |
| 86735 |
|
280 |
268 |
$3K |
| 90474 |
|
1,860 |
1,845 |
$3K |
| 90733 |
|
51 |
51 |
$3K |
| 12001 |
|
12 |
12 |
$3K |
| 90633 |
|
1,986 |
1,973 |
$3K |
| 96111 |
|
41 |
40 |
$3K |
| C1769 |
Guide wire |
1,673 |
1,310 |
$3K |
| 0003A |
|
183 |
181 |
$3K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
198 |
138 |
$3K |
| 87634 |
|
46 |
44 |
$3K |
| 86708 |
|
356 |
339 |
$3K |
| 93880 |
|
39 |
38 |
$2K |
| 87902 |
|
12 |
12 |
$2K |
| ATP18 |
|
628 |
489 |
$2K |
| 82805 |
|
79 |
71 |
$2K |
| 87338 |
|
207 |
206 |
$2K |
| 10061 |
|
12 |
12 |
$2K |
| 85045 |
|
1,099 |
933 |
$2K |
| 86707 |
|
224 |
218 |
$2K |
| 72131 |
|
60 |
57 |
$2K |
| 86320 |
|
94 |
94 |
$2K |
| 73090 |
|
573 |
483 |
$2K |
| 84590 |
|
254 |
250 |
$2K |
| 90716 |
|
661 |
655 |
$2K |
| 86147 |
|
88 |
54 |
$2K |
| 83521 |
|
228 |
206 |
$2K |
| 96112 |
|
14 |
13 |
$2K |
| 87350 |
|
201 |
198 |
$2K |
| ATP02 |
|
826 |
672 |
$2K |
| 36592 |
|
3,401 |
2,339 |
$2K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,817 |
1,331 |
$2K |
| 81370 |
|
93 |
77 |
$2K |
| 73521 |
|
104 |
103 |
$2K |
| 90653 |
|
263 |
259 |
$2K |
| 86800 |
|
154 |
148 |
$2K |
| 29075 |
|
16 |
12 |
$2K |
| 86146 |
|
82 |
49 |
$2K |
| 0144A |
|
41 |
41 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
560 |
531 |
$2K |
| 90746 |
|
58 |
54 |
$2K |
| 80320 |
|
849 |
772 |
$2K |
| 74019 |
|
119 |
118 |
$2K |
| 83921 |
|
150 |
140 |
$2K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
73 |
62 |
$2K |
| 84295 |
|
806 |
752 |
$2K |
| 99397 |
|
128 |
111 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,211 |
1,021 |
$2K |
| 95117 |
|
40 |
24 |
$2K |
| 86376 |
|
116 |
110 |
$1K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,017 |
571 |
$1K |
| 82627 |
|
77 |
76 |
$1K |
| 84270 |
|
93 |
90 |
$1K |
| 92556 |
|
39 |
39 |
$1K |
| ATP05 |
|
349 |
282 |
$1K |
| 85018 |
|
811 |
733 |
$1K |
| 99195 |
|
18 |
15 |
$1K |
| 86335 |
|
138 |
121 |
$1K |
| 86301 |
|
88 |
69 |
$1K |
| 76820 |
|
31 |
12 |
$1K |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
2,271 |
1,494 |
$1K |
| 17000 |
|
42 |
42 |
$1K |
| 90732 |
|
79 |
67 |
$1K |
| 76514 |
|
52 |
51 |
$1K |
| 72110 |
|
145 |
141 |
$1K |
| 99152 |
|
87 |
78 |
$1K |
| 88184 |
|
35 |
31 |
$1K |
| 85384 |
|
190 |
168 |
$1K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
694 |
660 |
$1K |
| 82330 |
|
192 |
171 |
$1K |
| J3590 |
Unclassified biologics |
29 |
24 |
$1K |
| 20600 |
|
20 |
14 |
$1K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,057 |
628 |
$1K |
| 77072 |
|
26 |
25 |
$1K |
| 89051 |
|
266 |
228 |
$1K |
| 99442 |
|
157 |
143 |
$1K |
| 94664 |
|
40 |
39 |
$1K |
| 90707 |
|
601 |
595 |
$1K |
| 90678 |
|
55 |
54 |
$1K |
| 97535 |
Self-care/home management training, each 15 minutes |
20 |
12 |
$1K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
942 |
630 |
$1K |
| 83525 |
|
96 |
95 |
$1K |
| A4222 |
Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) |
894 |
508 |
$996.06 |
| 82465 |
|
678 |
658 |
$995.51 |
| 84630 |
|
119 |
114 |
$971.21 |
| 87529 |
|
29 |
24 |
$966.64 |
| J3489 |
Injection, zoledronic acid, 1 mg |
183 |
153 |
$923.53 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
14 |
13 |
$900.00 |
| 97804 |
|
12 |
12 |
$880.04 |
| 82977 |
|
499 |
466 |
$866.74 |
| 88312 |
|
168 |
161 |
$862.95 |
| 94762 |
|
256 |
228 |
$857.84 |
| 91303 |
|
266 |
262 |
$836.29 |
| 93280 |
|
42 |
38 |
$833.93 |
| 90680 |
|
2,462 |
2,415 |
$823.32 |
| 82785 |
|
74 |
69 |
$820.06 |
| 96161 |
|
64 |
63 |
$787.84 |
| 85049 |
|
339 |
322 |
$783.72 |
| 76881 |
|
20 |
16 |
$771.42 |
| 90649 |
|
1,081 |
1,076 |
$765.85 |
| 86361 |
|
65 |
65 |
$759.15 |
| 87116 |
|
90 |
64 |
$732.16 |
| 82374 |
|
268 |
256 |
$730.03 |
| 76882 |
|
17 |
15 |
$681.34 |
| 91301 |
|
784 |
754 |
$669.79 |
| 95251 |
|
63 |
61 |
$656.53 |
| 84132 |
|
674 |
560 |
$652.24 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
138 |
64 |
$650.48 |
| 99188 |
|
15 |
15 |
$643.72 |
| 86592 |
|
200 |
193 |
$629.65 |
| 80299 |
|
62 |
55 |
$596.30 |
| 86665 |
|
45 |
36 |
$593.97 |
| 94727 |
|
13 |
13 |
$591.82 |
| 84445 |
|
13 |
13 |
$556.68 |
| 72070 |
|
15 |
15 |
$544.45 |
| 82024 |
|
12 |
12 |
$530.70 |
| G0009 |
Administration of pneumococcal vaccine |
449 |
438 |
$519.71 |
| 94761 |
|
1,753 |
1,499 |
$508.89 |
| 80074 |
|
12 |
12 |
$504.12 |
| 87449 |
|
77 |
68 |
$503.09 |
| 90658 |
|
793 |
792 |
$481.65 |
| J2060 |
Injection, lorazepam, 2 mg |
316 |
236 |
$477.36 |
| 83010 |
|
77 |
53 |
$463.52 |
| 99153 |
Mod sedat endo service >5yrs |
31 |
25 |
$445.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
677 |
574 |
$442.93 |
| 87075 |
|
82 |
70 |
$435.47 |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
294 |
290 |
$407.33 |
| 80329 |
|
851 |
768 |
$397.55 |
| 81000 |
|
145 |
141 |
$391.10 |
| 87807 |
|
51 |
50 |
$386.38 |
| 87206 |
|
108 |
79 |
$385.37 |
| 97116 |
|
14 |
12 |
$381.71 |
| 86308 |
|
81 |
80 |
$353.52 |
| 82525 |
|
39 |
38 |
$350.84 |
| 86364 |
|
33 |
30 |
$348.09 |
| 86705 |
|
40 |
40 |
$337.82 |
| 96127 |
|
295 |
295 |
$326.49 |
| 83498 |
|
13 |
13 |
$322.14 |
| 90744 |
|
1,715 |
1,695 |
$320.78 |
| J1630 |
Injection, haloperidol, up to 5 mg |
64 |
62 |
$313.59 |
| 74022 |
|
26 |
26 |
$310.95 |
| 76377 |
|
140 |
133 |
$287.99 |
| 85014 |
|
299 |
273 |
$285.29 |
| 82103 |
|
28 |
26 |
$248.85 |
| 86870 |
|
19 |
15 |
$245.81 |
| 84305 |
|
12 |
12 |
$232.80 |
| V2632 |
Posterior chamber intraocular lens |
538 |
498 |
$215.00 |
| 86258 |
|
12 |
12 |
$208.70 |
| 86381 |
|
12 |
12 |
$202.05 |
| 99443 |
|
31 |
29 |
$182.59 |
| 84244 |
|
13 |
12 |
$180.54 |
| 99243 |
|
109 |
107 |
$176.48 |
| 83519 |
|
13 |
12 |
$175.13 |
| 86828 |
|
24 |
24 |
$168.98 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
484 |
423 |
$168.73 |
| 51701 |
|
29 |
27 |
$154.77 |
| 82340 |
|
25 |
25 |
$154.76 |
| 82164 |
|
13 |
12 |
$145.77 |
| 82010 |
|
31 |
25 |
$144.20 |
| 99024 |
|
486 |
421 |
$141.34 |
| 0296T |
|
14 |
14 |
$141.15 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
1,034 |
1,014 |
$133.67 |
| 93246 |
|
29 |
29 |
$132.12 |
| 84432 |
|
13 |
13 |
$124.47 |
| 87015 |
|
25 |
13 |
$120.70 |
| 86593 |
|
41 |
40 |
$117.65 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
62 |
54 |
$116.17 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
29 |
25 |
$115.52 |
| 85390 |
|
14 |
13 |
$114.40 |
| 83718 |
|
129 |
128 |
$105.17 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
30 |
30 |
$98.61 |
| 80164 |
|
28 |
25 |
$97.86 |
| 88300 |
|
97 |
81 |
$93.23 |
| L1820 |
Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
13 |
12 |
$92.43 |
| 84300 |
|
26 |
24 |
$91.87 |
| 90698 |
|
2,789 |
2,738 |
$90.78 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
25 |
25 |
$86.62 |
| 82390 |
|
12 |
12 |
$85.23 |
| 88311 |
|
14 |
14 |
$72.40 |
| 80503 |
|
43 |
39 |
$72.33 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
63 |
61 |
$66.87 |
| 87324 |
|
47 |
40 |
$59.05 |
| A4344 |
Indwelling catheter, foley type, two-way, all silicone or polyurethane, each |
12 |
12 |
$57.90 |
| M0220 |
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring |
19 |
15 |
$54.00 |
| Q2039 |
Influenza virus vaccine, not otherwise specified |
120 |
115 |
$50.85 |
| ATP21 |
|
13 |
13 |
$49.28 |
| 90710 |
|
602 |
598 |
$48.98 |
| 73060 |
|
13 |
12 |
$40.33 |
| 93321 |
|
16 |
15 |
$34.75 |
| A4311 |
Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) |
181 |
152 |
$32.29 |
| 91312 |
|
718 |
692 |
$25.07 |
| J3473 |
Injection, hyaluronidase, recombinant, 1 usp unit |
284 |
264 |
$22.95 |
| 91313 |
|
422 |
398 |
$3.72 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
201 |
166 |
$3.33 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
110 |
79 |
$2.56 |
| J1836 |
Injection, metronidazole, 10 mg |
18 |
12 |
$1.84 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
119 |
68 |
$0.20 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
181 |
167 |
$0.00 |
| 90473 |
|
368 |
361 |
$0.00 |
| 0690T |
|
394 |
388 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
178 |
149 |
$0.00 |
| 90785 |
|
34 |
26 |
$0.00 |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
48 |
48 |
$0.00 |
| 90461 |
|
15 |
15 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
218 |
199 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
101 |
90 |
$0.00 |
| 11720 |
|
12 |
12 |
$0.00 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
22 |
13 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
26 |
25 |
$0.00 |
| J1245 |
Injection, dipyridamole, per 10 mg |
12 |
12 |
$0.00 |
| 91321 |
|
128 |
125 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
12 |
12 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
15 |
12 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
14 |
13 |
$0.00 |
| Q0220 |
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg |
38 |
15 |
$0.00 |
| 76981 |
|
14 |
13 |
$0.00 |
| 90700 |
|
12 |
12 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
27 |
25 |
$0.00 |
| 90657 |
|
630 |
629 |
$0.00 |
| 46600 |
|
26 |
25 |
$0.00 |
| 90702 |
|
288 |
280 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
48 |
44 |
$0.00 |
| 90696 |
|
532 |
532 |
$0.00 |
| 91307 |
|
521 |
495 |
$0.00 |
| A4615 |
Cannula, nasal |
12 |
12 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
39 |
37 |
$0.00 |
| J0173 |
Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg |
13 |
13 |
$0.00 |
| 99406 |
|
13 |
12 |
$0.00 |
| 81599 |
|
13 |
12 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
17 |
13 |
$0.00 |